A type i interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation

Federica Rascio, Paola Pontrelli, Matteo Accetturo, Annarita Oranger, Margherita Gigante, Giuseppe Castellano, Maddalena Gigante, Anna Zito, Gianluigi Zaza, Antonio Lupo, Elena Ranieri, Giovanni Stallone, Loreto Gesualdo, Giuseppe Grandaliano

Risultato della ricerca: Contributo in rivistaArticolo in rivista

30 Citazioni (Scopus)


Chronic antibody-mediated rejection (CAMR) represents the main cause of kidney graft loss. To uncover the molecular mechanisms underlying this condition, we characterized the molecular signature of peripheral blood mononuclear cells (PBMCs) and, separately, of CD4+ T lymphocytes isolated from CAMR patients, compared to kidney transplant recipients with normal graft function and histology. We enrolled 29 patients with biopsy-proven CAMR, 29 stable transplant recipients (controls), and 8 transplant recipients with clinical and histological evidence of interstitial fibrosis/tubular atrophy. Messenger RNA and microRNA profiling of PBMCs and CD4+ T lymphocytes was performed using Agilent microarrays in eight randomly selected patients per group from CAMR and control subjects. Results were evaluated statistically and by functional pathway analysis (Ingenuity Pathway Analysis) and validated in the remaining subjects. In PBMCs, 45 genes were differentially expressed between the two groups, most of which were up-regulated in CAMR and were involved in type I interferon signalling. In the same patients, 16 microRNAs were down-regulated in CAMR subjects compared to controls: four were predicted modulators of six mRNAs identified in the transcriptional analysis. In silico functional analysis supported the involvement of type I interferon signalling. To further confirm this result, we investigated the transcriptomic profiles of CD4+ T lymphocytes in an independent group of patients, observing that the activation of type I interferon signalling was a specific hallmark of CAMR. In addition, in CAMR patients, we detected a reduction of circulating BDCA2+ dendritic cells, the natural type I interferon-producing cells, and their recruitment into the graft along with increased expression of MXA, a type I interferon-induced protein, at the tubulointerstitial and vascular level. Finally, interferon alpha mRNA expression was significantly increased in CAMR compared to control biopsies. We conclude that type I interferon signalling may represent the molecular signature of CAMR.
Lingua originaleEnglish
pagine (da-a)72-84
Numero di pagine13
RivistaJournal of Pathology
Stato di pubblicazionePubblicato - 2015


  • Adult
  • Aged
  • Biomarkers
  • Biopsy
  • CD4-Positive T-Lymphocytes
  • Case-Control Studies
  • Chronic Disease
  • Female
  • Gene Expression Profiling
  • Gene Expression Regulation
  • Gene Regulatory Networks
  • Genetic Association Studies
  • Graft Rejection
  • Humans
  • Interferon Type I
  • Kidney
  • Kidney Transplantation
  • Leukocytes, Mononuclear
  • Male
  • MicroRNAs
  • Middle Aged
  • Oligonucleotide Array Sequence Analysis
  • RNA, Messenger
  • Signal Transduction
  • T lymphocytes
  • Transcription, Genetic
  • Transcriptome
  • Treatment Outcome
  • chronic antibody-mediated rejection
  • immunology
  • kidney transplantation
  • messenger RNA and microRNA profiling
  • peripheral blood mononuclear cells
  • type I interferon


Entra nei temi di ricerca di 'A type i interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation'. Insieme formano una fingerprint unica.

Cita questo